Author Details

Самойленко, Игорь Вячеславович

Issue	Section	Title	File
Vol 16, No 1 (2014)	Articles	Overcoming immunological tolerance is a way of treating malignant tumors: new perspectives	() () () () ()
Vol 17, No 3 (2015)	Articles	Osobennosti korrektsii naibolee chastykh nezhelatel'nykh yavleniy na fone primeneniya ingibitorov BRAF i MEK	() () () () ()
Vol 24, No 4 (2022)	CLINICAL ONCOLOGY	Real-world efficacy of the first line therapy with prolgolimab in patients with metastatic melanoma: interim results of the FORA (FOrteca Real practice Assessment) observational study	(Rus)
Vol 25, No 3 (2023)	CLINICAL ONCOLOGY	Membrane (CD8⁺PD-1⁺ and CD4+PD-1⁺) and soluble (sPD-1 and sPD-L1) forms of immune checkpoints in melanoma, breast cancer, and oral mucosal cancer patients: A observational study	(Rus)
Vol 25, No 3 (2023)	CLINICAL ONCOLOGY	Efficacy and safety of nurulimab+prolgolimab with continued prolgolimab therapy compared to prolgolimab alone as first-line therapy in patients with unresectable or metastatic melanoma: final results of the phase II OBERTON clinical study	(Rus)
Vol 26, No 1 (2024)	Articles	Final data on the eﬃcacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world eﬃcacy of prolgolimab in patients with metastatic melanoma in Russia	(Rus)
Vol 27, No 3 (2025)	Articles	Comparative efficacy and safety of prolgolimab + nurulimab and nivolumab + ipilimumab in the first-line therapy of metastatic or unresectable melanoma: A systematic review and matching-adjusted indirect comparison	(Rus)
Vol 27, No 3 (2025)	Articles	Adjuvant targeted therapy in patients with skin melanoma: evidence from Russian real-world clinical practice (RATIONALE study)	(Rus)

Username
Password
Remember me

Forgot password?	Register

Username
Password
Remember me

Forgot password?	Register